Wenhang Xu received her bachelor's degree from West China School of Pharmacy, Sichuan University in 2025. She is currently a master's student at Fudan University, focusing on advanced PBPK modelling and tumour digital twin technologies. Her research aims to integrate computational simulations with clinical data to optimise personalised cancer therapies and improve patient outcomes.